28 jun: Når lav risiko giver højt afkast
17 jul: Test
28-06-2012 11:45:00

Veolia Sells UK Water, Says On Track for Other Sales

Relateret indhold

PARIS--French waste and water utility Veolia Environnement SA (VE) Thursday completed the first leg of a substantial disposal plan by selling its U.K. regulated water business for 1.24 billion pounds ($1.94 billion), with most of the proceeds going towards cutting its huge debt pile.

Paris-listed Veolia, the world's largest environmental utility by revenue, has sold the business to Rift Acquisitions Ltd.--an entity formed by Prudential PLC's (PUK) Infracapital Partners and Morgan Stanley Infrastructure Partners, a unit of Morgan Stanley (MS). The sale, expected to be finalized as of Thursday as it isn't subject to conditions, should allow Veolia to cut its EUR15 billion net debt by EUR1.45 billion, it said.

The move is the first of a series of planned asset sales worth EUR5 billion, as Veolia battles to restore profitability and its financial room for maneuver following an accounting fraud in the U.S. and substantial write-offs last year due to poor performances in southern Europe and northern Africa. The downsizing is all the more crucial as the economic crisis deepens in Europe and municipalities, troubled by financing issues, question contracts to handle their water networks and even their waste.

Veolia said that it will retain a 10% equity interest in the regulated business through Veolia Water UK for at least five years. Its non-regulated U.K. water operations aren't involved.

The news sent Veolia's shares higher at open. At 0905 GMT, shares were trading up 1.4% to EUR10.36 while the CAC-40 benchmark index was down 0.8%.

A Paris-based trader said the sale was positive.

"The deal allows the company to reduce its debt which is encouraging," he said, adding that the move "comes as good news after the Transdev issues," in reference to Veolia's transport unit division, which it is also seeking to sell.

"This first significant divestment shows that we are moving in the right direction regarding the implementation of our strategic plan and that the transformation of Veolia is progressing at a good pace," Veolia's Chairman and Chief Executive Antoine Frerot said in a statement.

Veolia also hopes to sell its U.S. solid waste business this summer and has already lined up "more than three buyers," comprising industrial companies as well as financial funds, a person familiar with the matter said without elaborating on the identity of the suitors. A deal is expected to be signed in late July and close before the fall, the person said.

The disposal of part of Veolia's stake in Transdev is proceeding less smoothly. French state-owned financial firm Caisse des Depots et Consignations, which owns half of Transdev, is reported to have turned down a proposal by investment fund Cube, a unit of French bank Natixis (KN.FR). It is also reported to have rejected the possibility of increasing its own stake by buying some of Veolia's shares.

Veolia has initiated discussions with an industrial group as a contingency plan, the person said.

Write to Geraldine Amiel at geraldine.amiel@dowjones.com

(END) Dow Jones Newswires

June 28, 2012 05:45 ET (09:45 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Genmab/IR: Royalties vil som minimum dække omkostningerne næste år

12-12-2017 14:04:43
Genmabs royaltyindtægter fra salget af selskabets kræftmidler vil i 2018 som minimum dække omkostningerne.Det præciserer Genmabs IR- og kommunikationsdirektør, Rachel Curtis Gravesen, i en e-mail over for Ritzau Finans, efter at selskabet i nattens løb er kommet med en foreløbig prognose for 2018, som angiveligt har givet anledning til en del tolkning i analytikerkredse vedrørende salget af Genmab..

Aktier/middag: Genmab ryger ned på usikkerhed om 2018-forventninger

12-12-2017 11:39:38
Genmab er under hårdt pres på det danske aktiemarked tirsdag, da flere investorer har tolket negativt på ledelsens udmeldinger om 2018 og nu regner med et lavere salg af kræftmidlet Darzalex end tidligere.Aktien dykker 7,7 pct. til 1093 kr. - det største fald i små to år - og nedturen for biotekaktien er med til at tynge C20 Cap-indekset, som dykker 0,3 pct. til 1125,54.Genmab afholdt natten til t..

Aktier/tendens: SAS klar med endelige regnskabstal før handelsstart

12-12-2017 08:15:47
Luftfartsselskabet SAS offentliggjorde forud for børsåbningen tirsdag sit endelige regnskab for det skæve regnskabsår 2016/17, og selskabet kan derfor løbe med en del af opmærksomheden ved handelsstart.Det danske aktiemarked kan gå endnu en grøn dag i møde på det ledende eliteindeks, hvis den amerikanske grønne bølge forplanter sig på de europæiske markeder.Mandag fik C20 Cap-indekset en positiv s..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Genmab/Jefferies: Svært at se væsentlig konkurrencerisiko
2
Genmab-aktien får kurstæsk efter forsigtig udmelding fra ledelsen
3
Genmab-aktien får kurstæsk efter forsigtig udmelding fra ledelsen - NY
4
Novo-rival for godkendt kopiprodukt
5
Ørsted opjusterer forventninger efter delvist salg af havmøllepark -NY

Relaterede aktiekurser

Prudential PLC ORD 5P 1.828,00 -0,6% Fald i aktiekurs
Natixis 6,80 0,2% Stigning i aktiekurs
Veolia Environ 21,12 0,0% Aktiekurs uændret
Morgan Stanley 53,09 0,6% Stigning i aktiekurs
Prudential Public Limite.. 49,09 0,0% Aktiekurs uændret
Prudential USD 24,44 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
12. december 2017 17:10:56
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB4 - 2017-12-12 17:10:56 - 2017-12-12 17:10:56 - 1 - Website: OKAY